Longitudinal cortical thinning and cognitive decline in patients with early‐ versus late‐stage subcortical vascular mild cognitive impairment

Background and purpose Biomarker changes in cognitively impaired patients with small vessel disease are largely unknown. The rate of amyloid/lacune progression, cortical thinning and cognitive decline were evaluated in subcortical vascular mild cognitive impairment (svMCI) patients. Methods Seventy‐...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of neurology 2018-02, Vol.25 (2), p.326-333
Hauptverfasser: Lee, J., Seo, S. W., Yang, J.‐J., Jang, Y. K., Lee, J. S., Kim, Y. J., Chin, J., Lee, J. M., Kim, S. T., Lee, K.‐H., Lee, J. H., Kim, J. S., Kim, S., Yoo, H., Lee, A. Y., Na, D. L., Kim, H. J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 333
container_issue 2
container_start_page 326
container_title European journal of neurology
container_volume 25
creator Lee, J.
Seo, S. W.
Yang, J.‐J.
Jang, Y. K.
Lee, J. S.
Kim, Y. J.
Chin, J.
Lee, J. M.
Kim, S. T.
Lee, K.‐H.
Lee, J. H.
Kim, J. S.
Kim, S.
Yoo, H.
Lee, A. Y.
Na, D. L.
Kim, H. J.
description Background and purpose Biomarker changes in cognitively impaired patients with small vessel disease are largely unknown. The rate of amyloid/lacune progression, cortical thinning and cognitive decline were evaluated in subcortical vascular mild cognitive impairment (svMCI) patients. Methods Seventy‐two svMCI patients were divided into early stage (ES‐svMCI, n = 39) and late stage (LS‐svMCI, n = 33) according to their Clinical Dementia Rating Sum of Boxes score. Patients were annually followed up with neuropsychological tests and brain magnetic resonance imaging for 3 years, and underwent a second [11C] Pittsburgh compound B (PiB) positron emission tomography scan within a mean interval of 32.4 months. Results There was no difference in the rate of increase in PiB uptake or lacune number between the ES‐svMCI and LS‐svMCI. However, LS‐svMCI showed more rapid cortical thinning and cognitive decline than did the ES‐svMCI. Conclusions We suggest that, whilst the rate of change in pathological burden did not differ between ES‐svMCI and LS‐svMCI, cortical thinning and cognitive decline progressed more rapidly in the LS‐svMCI.
doi_str_mv 10.1111/ene.13500
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1957768070</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1989563614</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3530-a1cb2506f400a8f79de78d3c5ec0453cc30505c4a71816f9ad3ae338058b1b8e3</originalsourceid><addsrcrecordid>eNp1kc9u1DAQhy0EoqVw4AWQJS5wSDuO48Q5omopSKtygXPkOJPtVI6z2M5We-MR4BV5krpsqSok5jJ_9Ok7zI-x1wJORa4z9HgqpAJ4wo5FVetCSCme5lkqUSgB4oi9iPEaAMqmhOfsqGxBl6qpj9mv9ew3lJaBvHHcziGRzUO6Iu_Jb7jxQ75uPCXaIR_QOvLIyfOtSYQ-RX5D6YqjCW7_-8dPvsMQl8idSZjXmMwGeVz6B_HORLs4E_hE7rGZpq2hMGXjS_ZsNC7iq_t-wr59XH09_1Ssv1x8Pv-wLqxUEgojbF8qqMcKwOixaQds9CCtQguVktZKUKBsZRqhRT22ZpAGpdSgdC96jfKEvTt4t2H-vmBM3UTRonPG47zETrSqaWoNDWT07T_o9byE_LA7SreqlrWoMvX-QNkwxxhw7LaBJhP2nYDuLqcu59T9ySmzb-6NSz_h8ED-DSYDZwfghhzu_2_qVperg_IWsC6g5A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1989563614</pqid></control><display><type>article</type><title>Longitudinal cortical thinning and cognitive decline in patients with early‐ versus late‐stage subcortical vascular mild cognitive impairment</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Lee, J. ; Seo, S. W. ; Yang, J.‐J. ; Jang, Y. K. ; Lee, J. S. ; Kim, Y. J. ; Chin, J. ; Lee, J. M. ; Kim, S. T. ; Lee, K.‐H. ; Lee, J. H. ; Kim, J. S. ; Kim, S. ; Yoo, H. ; Lee, A. Y. ; Na, D. L. ; Kim, H. J.</creator><creatorcontrib>Lee, J. ; Seo, S. W. ; Yang, J.‐J. ; Jang, Y. K. ; Lee, J. S. ; Kim, Y. J. ; Chin, J. ; Lee, J. M. ; Kim, S. T. ; Lee, K.‐H. ; Lee, J. H. ; Kim, J. S. ; Kim, S. ; Yoo, H. ; Lee, A. Y. ; Na, D. L. ; Kim, H. J.</creatorcontrib><description>Background and purpose Biomarker changes in cognitively impaired patients with small vessel disease are largely unknown. The rate of amyloid/lacune progression, cortical thinning and cognitive decline were evaluated in subcortical vascular mild cognitive impairment (svMCI) patients. Methods Seventy‐two svMCI patients were divided into early stage (ES‐svMCI, n = 39) and late stage (LS‐svMCI, n = 33) according to their Clinical Dementia Rating Sum of Boxes score. Patients were annually followed up with neuropsychological tests and brain magnetic resonance imaging for 3 years, and underwent a second [11C] Pittsburgh compound B (PiB) positron emission tomography scan within a mean interval of 32.4 months. Results There was no difference in the rate of increase in PiB uptake or lacune number between the ES‐svMCI and LS‐svMCI. However, LS‐svMCI showed more rapid cortical thinning and cognitive decline than did the ES‐svMCI. Conclusions We suggest that, whilst the rate of change in pathological burden did not differ between ES‐svMCI and LS‐svMCI, cortical thinning and cognitive decline progressed more rapidly in the LS‐svMCI.</description><identifier>ISSN: 1351-5101</identifier><identifier>EISSN: 1468-1331</identifier><identifier>DOI: 10.1111/ene.13500</identifier><identifier>PMID: 29082576</identifier><language>eng</language><publisher>England: John Wiley &amp; Sons, Inc</publisher><subject>Aged ; Aged, 80 and over ; Amyloid ; Biomarkers ; Brain ; Cerebral Cortex - diagnostic imaging ; Cerebral Small Vessel Diseases - complications ; Cerebral Small Vessel Diseases - diagnostic imaging ; cognition ; Cognitive ability ; Cognitive Dysfunction - etiology ; Cognitive Dysfunction - physiopathology ; Cortex ; cortical thickness ; Dementia disorders ; Disease Progression ; early stage ; Female ; Humans ; Impairment ; late stage ; Longitudinal Studies ; Magnetic resonance imaging ; Magnetic Resonance Imaging - methods ; Male ; Mental competency ; Neuroimaging ; Neuropsychological Tests ; Patients ; Positron emission ; Positron emission tomography ; Positron-Emission Tomography - methods ; subcortical vascular mild cognitive impairment ; Thinning</subject><ispartof>European journal of neurology, 2018-02, Vol.25 (2), p.326-333</ispartof><rights>2017 EAN</rights><rights>2017 EAN.</rights><rights>Copyright © 2018 European Academy of Neurology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3530-a1cb2506f400a8f79de78d3c5ec0453cc30505c4a71816f9ad3ae338058b1b8e3</citedby><cites>FETCH-LOGICAL-c3530-a1cb2506f400a8f79de78d3c5ec0453cc30505c4a71816f9ad3ae338058b1b8e3</cites><orcidid>0000-0002-5017-854X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fene.13500$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fene.13500$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29082576$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, J.</creatorcontrib><creatorcontrib>Seo, S. W.</creatorcontrib><creatorcontrib>Yang, J.‐J.</creatorcontrib><creatorcontrib>Jang, Y. K.</creatorcontrib><creatorcontrib>Lee, J. S.</creatorcontrib><creatorcontrib>Kim, Y. J.</creatorcontrib><creatorcontrib>Chin, J.</creatorcontrib><creatorcontrib>Lee, J. M.</creatorcontrib><creatorcontrib>Kim, S. T.</creatorcontrib><creatorcontrib>Lee, K.‐H.</creatorcontrib><creatorcontrib>Lee, J. H.</creatorcontrib><creatorcontrib>Kim, J. S.</creatorcontrib><creatorcontrib>Kim, S.</creatorcontrib><creatorcontrib>Yoo, H.</creatorcontrib><creatorcontrib>Lee, A. Y.</creatorcontrib><creatorcontrib>Na, D. L.</creatorcontrib><creatorcontrib>Kim, H. J.</creatorcontrib><title>Longitudinal cortical thinning and cognitive decline in patients with early‐ versus late‐stage subcortical vascular mild cognitive impairment</title><title>European journal of neurology</title><addtitle>Eur J Neurol</addtitle><description>Background and purpose Biomarker changes in cognitively impaired patients with small vessel disease are largely unknown. The rate of amyloid/lacune progression, cortical thinning and cognitive decline were evaluated in subcortical vascular mild cognitive impairment (svMCI) patients. Methods Seventy‐two svMCI patients were divided into early stage (ES‐svMCI, n = 39) and late stage (LS‐svMCI, n = 33) according to their Clinical Dementia Rating Sum of Boxes score. Patients were annually followed up with neuropsychological tests and brain magnetic resonance imaging for 3 years, and underwent a second [11C] Pittsburgh compound B (PiB) positron emission tomography scan within a mean interval of 32.4 months. Results There was no difference in the rate of increase in PiB uptake or lacune number between the ES‐svMCI and LS‐svMCI. However, LS‐svMCI showed more rapid cortical thinning and cognitive decline than did the ES‐svMCI. Conclusions We suggest that, whilst the rate of change in pathological burden did not differ between ES‐svMCI and LS‐svMCI, cortical thinning and cognitive decline progressed more rapidly in the LS‐svMCI.</description><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Amyloid</subject><subject>Biomarkers</subject><subject>Brain</subject><subject>Cerebral Cortex - diagnostic imaging</subject><subject>Cerebral Small Vessel Diseases - complications</subject><subject>Cerebral Small Vessel Diseases - diagnostic imaging</subject><subject>cognition</subject><subject>Cognitive ability</subject><subject>Cognitive Dysfunction - etiology</subject><subject>Cognitive Dysfunction - physiopathology</subject><subject>Cortex</subject><subject>cortical thickness</subject><subject>Dementia disorders</subject><subject>Disease Progression</subject><subject>early stage</subject><subject>Female</subject><subject>Humans</subject><subject>Impairment</subject><subject>late stage</subject><subject>Longitudinal Studies</subject><subject>Magnetic resonance imaging</subject><subject>Magnetic Resonance Imaging - methods</subject><subject>Male</subject><subject>Mental competency</subject><subject>Neuroimaging</subject><subject>Neuropsychological Tests</subject><subject>Patients</subject><subject>Positron emission</subject><subject>Positron emission tomography</subject><subject>Positron-Emission Tomography - methods</subject><subject>subcortical vascular mild cognitive impairment</subject><subject>Thinning</subject><issn>1351-5101</issn><issn>1468-1331</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kc9u1DAQhy0EoqVw4AWQJS5wSDuO48Q5omopSKtygXPkOJPtVI6z2M5We-MR4BV5krpsqSok5jJ_9Ok7zI-x1wJORa4z9HgqpAJ4wo5FVetCSCme5lkqUSgB4oi9iPEaAMqmhOfsqGxBl6qpj9mv9ew3lJaBvHHcziGRzUO6Iu_Jb7jxQ75uPCXaIR_QOvLIyfOtSYQ-RX5D6YqjCW7_-8dPvsMQl8idSZjXmMwGeVz6B_HORLs4E_hE7rGZpq2hMGXjS_ZsNC7iq_t-wr59XH09_1Ssv1x8Pv-wLqxUEgojbF8qqMcKwOixaQds9CCtQguVktZKUKBsZRqhRT22ZpAGpdSgdC96jfKEvTt4t2H-vmBM3UTRonPG47zETrSqaWoNDWT07T_o9byE_LA7SreqlrWoMvX-QNkwxxhw7LaBJhP2nYDuLqcu59T9ySmzb-6NSz_h8ED-DSYDZwfghhzu_2_qVperg_IWsC6g5A</recordid><startdate>201802</startdate><enddate>201802</enddate><creator>Lee, J.</creator><creator>Seo, S. W.</creator><creator>Yang, J.‐J.</creator><creator>Jang, Y. K.</creator><creator>Lee, J. S.</creator><creator>Kim, Y. J.</creator><creator>Chin, J.</creator><creator>Lee, J. M.</creator><creator>Kim, S. T.</creator><creator>Lee, K.‐H.</creator><creator>Lee, J. H.</creator><creator>Kim, J. S.</creator><creator>Kim, S.</creator><creator>Yoo, H.</creator><creator>Lee, A. Y.</creator><creator>Na, D. L.</creator><creator>Kim, H. J.</creator><general>John Wiley &amp; Sons, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7U7</scope><scope>C1K</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5017-854X</orcidid></search><sort><creationdate>201802</creationdate><title>Longitudinal cortical thinning and cognitive decline in patients with early‐ versus late‐stage subcortical vascular mild cognitive impairment</title><author>Lee, J. ; Seo, S. W. ; Yang, J.‐J. ; Jang, Y. K. ; Lee, J. S. ; Kim, Y. J. ; Chin, J. ; Lee, J. M. ; Kim, S. T. ; Lee, K.‐H. ; Lee, J. H. ; Kim, J. S. ; Kim, S. ; Yoo, H. ; Lee, A. Y. ; Na, D. L. ; Kim, H. J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3530-a1cb2506f400a8f79de78d3c5ec0453cc30505c4a71816f9ad3ae338058b1b8e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Amyloid</topic><topic>Biomarkers</topic><topic>Brain</topic><topic>Cerebral Cortex - diagnostic imaging</topic><topic>Cerebral Small Vessel Diseases - complications</topic><topic>Cerebral Small Vessel Diseases - diagnostic imaging</topic><topic>cognition</topic><topic>Cognitive ability</topic><topic>Cognitive Dysfunction - etiology</topic><topic>Cognitive Dysfunction - physiopathology</topic><topic>Cortex</topic><topic>cortical thickness</topic><topic>Dementia disorders</topic><topic>Disease Progression</topic><topic>early stage</topic><topic>Female</topic><topic>Humans</topic><topic>Impairment</topic><topic>late stage</topic><topic>Longitudinal Studies</topic><topic>Magnetic resonance imaging</topic><topic>Magnetic Resonance Imaging - methods</topic><topic>Male</topic><topic>Mental competency</topic><topic>Neuroimaging</topic><topic>Neuropsychological Tests</topic><topic>Patients</topic><topic>Positron emission</topic><topic>Positron emission tomography</topic><topic>Positron-Emission Tomography - methods</topic><topic>subcortical vascular mild cognitive impairment</topic><topic>Thinning</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lee, J.</creatorcontrib><creatorcontrib>Seo, S. W.</creatorcontrib><creatorcontrib>Yang, J.‐J.</creatorcontrib><creatorcontrib>Jang, Y. K.</creatorcontrib><creatorcontrib>Lee, J. S.</creatorcontrib><creatorcontrib>Kim, Y. J.</creatorcontrib><creatorcontrib>Chin, J.</creatorcontrib><creatorcontrib>Lee, J. M.</creatorcontrib><creatorcontrib>Kim, S. T.</creatorcontrib><creatorcontrib>Lee, K.‐H.</creatorcontrib><creatorcontrib>Lee, J. H.</creatorcontrib><creatorcontrib>Kim, J. S.</creatorcontrib><creatorcontrib>Kim, S.</creatorcontrib><creatorcontrib>Yoo, H.</creatorcontrib><creatorcontrib>Lee, A. Y.</creatorcontrib><creatorcontrib>Na, D. L.</creatorcontrib><creatorcontrib>Kim, H. J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, J.</au><au>Seo, S. W.</au><au>Yang, J.‐J.</au><au>Jang, Y. K.</au><au>Lee, J. S.</au><au>Kim, Y. J.</au><au>Chin, J.</au><au>Lee, J. M.</au><au>Kim, S. T.</au><au>Lee, K.‐H.</au><au>Lee, J. H.</au><au>Kim, J. S.</au><au>Kim, S.</au><au>Yoo, H.</au><au>Lee, A. Y.</au><au>Na, D. L.</au><au>Kim, H. J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Longitudinal cortical thinning and cognitive decline in patients with early‐ versus late‐stage subcortical vascular mild cognitive impairment</atitle><jtitle>European journal of neurology</jtitle><addtitle>Eur J Neurol</addtitle><date>2018-02</date><risdate>2018</risdate><volume>25</volume><issue>2</issue><spage>326</spage><epage>333</epage><pages>326-333</pages><issn>1351-5101</issn><eissn>1468-1331</eissn><abstract>Background and purpose Biomarker changes in cognitively impaired patients with small vessel disease are largely unknown. The rate of amyloid/lacune progression, cortical thinning and cognitive decline were evaluated in subcortical vascular mild cognitive impairment (svMCI) patients. Methods Seventy‐two svMCI patients were divided into early stage (ES‐svMCI, n = 39) and late stage (LS‐svMCI, n = 33) according to their Clinical Dementia Rating Sum of Boxes score. Patients were annually followed up with neuropsychological tests and brain magnetic resonance imaging for 3 years, and underwent a second [11C] Pittsburgh compound B (PiB) positron emission tomography scan within a mean interval of 32.4 months. Results There was no difference in the rate of increase in PiB uptake or lacune number between the ES‐svMCI and LS‐svMCI. However, LS‐svMCI showed more rapid cortical thinning and cognitive decline than did the ES‐svMCI. Conclusions We suggest that, whilst the rate of change in pathological burden did not differ between ES‐svMCI and LS‐svMCI, cortical thinning and cognitive decline progressed more rapidly in the LS‐svMCI.</abstract><cop>England</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>29082576</pmid><doi>10.1111/ene.13500</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-5017-854X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1351-5101
ispartof European journal of neurology, 2018-02, Vol.25 (2), p.326-333
issn 1351-5101
1468-1331
language eng
recordid cdi_proquest_miscellaneous_1957768070
source MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects Aged
Aged, 80 and over
Amyloid
Biomarkers
Brain
Cerebral Cortex - diagnostic imaging
Cerebral Small Vessel Diseases - complications
Cerebral Small Vessel Diseases - diagnostic imaging
cognition
Cognitive ability
Cognitive Dysfunction - etiology
Cognitive Dysfunction - physiopathology
Cortex
cortical thickness
Dementia disorders
Disease Progression
early stage
Female
Humans
Impairment
late stage
Longitudinal Studies
Magnetic resonance imaging
Magnetic Resonance Imaging - methods
Male
Mental competency
Neuroimaging
Neuropsychological Tests
Patients
Positron emission
Positron emission tomography
Positron-Emission Tomography - methods
subcortical vascular mild cognitive impairment
Thinning
title Longitudinal cortical thinning and cognitive decline in patients with early‐ versus late‐stage subcortical vascular mild cognitive impairment
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T06%3A15%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Longitudinal%20cortical%20thinning%20and%20cognitive%20decline%20in%20patients%20with%20early%E2%80%90%20versus%20late%E2%80%90stage%20subcortical%20vascular%20mild%20cognitive%20impairment&rft.jtitle=European%20journal%20of%20neurology&rft.au=Lee,%20J.&rft.date=2018-02&rft.volume=25&rft.issue=2&rft.spage=326&rft.epage=333&rft.pages=326-333&rft.issn=1351-5101&rft.eissn=1468-1331&rft_id=info:doi/10.1111/ene.13500&rft_dat=%3Cproquest_cross%3E1989563614%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1989563614&rft_id=info:pmid/29082576&rfr_iscdi=true